Disseminated Mycobacterium kansasii Infection With Pulmonary Alveolar Proteinosis in a Patient with Chronic Myelogenous Leukemia

American Journal of Hematology

Volumn 74, Issue 3, 2003, Pages 221-223

  Goldschmidt, Neta ^a   Nusair, Samir ^a   Gural, Alexander ^a   Amir, Gail ^a   Izhar, Uzi ^a   Laxer, Uri ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Chronic myelogenous leukemia; Granulocyte macrophage colony stimulating factor; Mycobacterium kansasii; Pulmonary alveolar proteinosis; Surfactant protein A

Indexed keywords

ANAGRELIDE; CLARITHROMYCIN; ETHAMBUTOL; HYDROXYUREA; IMATINIB; ISONIAZID; PROTEIN TYROSINE KINASE INHIBITOR; RIFAMPICIN; STEROID;

ACINETOBACTER; ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD CULTURE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; FEMALE; FEVER; HOST RESISTANCE; HUMAN; LIVER DISEASE; LUNG ALVEOLUS PROTEINOSIS; LUNG INFILTRATE; LUNG LAVAGE; MYCOBACTERIUM KANSASII; OPEN LUNG BIOPSY; PRIORITY JOURNAL; SEPTIC SHOCK;

FATAL OUTCOME; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIC INFILTRATION; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; PULMONARY ALVEOLAR PROTEINOSIS; SHOCK, SEPTIC;

EID: 0242361650     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10410     Document Type: Article

References (10)

1. Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 2000;55:67-77.
2. Tsushima K, Koyama S, Saitou H, Takematsu H, Ichiyoshi T, Kubo K. Pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia. Respiration 1999;66:173-175.
3. Birsak CA, Van Rossem RN, Nijhuis-Heddes JMA, Maartense E. Pulmonary alveolar proteinosis: a complication in patients with hematopoietic malignancy. Neth J Med 2000;56:193-197.
4. Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994;264:713-716.
5. Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994;91;5592-5596.
6. Ikegami M, Ueda T, Hull W, et al. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am J Physiol 1996;270:L650-658.
7. Davies PD. Infection with Mycobacterium kansasii, editorials. Thorax 1994;49:435-436.
8. Grillo-Lopez AJ, Rivera E, Castillo-Staab M, Maldonado N. Disseminated M. kansasii infection in a patient with chronic granulocytic leukemia. Cancer 1971;28:476-481.
9. Gaynor CD, McKormack FX, Voelker DR, McGowan SE, Schlesinger LS. Pulmonary surfactant protein A mediates enhanced phagocytosis of mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 1995;155:5343-5351.
10. Pasula R, Dowing JF, Wright JR, Kachel DL, Davis TE Jr, Martin WJ 2nd. Surfactant protein A (SP-A) mediates attachment of mycobacterium tuberculosis to murine alveolar macrophages. Am J Respir Cell Mol Biol 1997;17:209-217.